ArticleInterdisciplinary sciences, computational life sciences2026
IHDFN-DTI: Interpretable Hybrid Deep Feature Fusion Network for Drug-Target Interaction Prediction.
Article in Interdisciplinary sciences, computational life sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Decoupling topological and molecular features for interpretable biomolecular interaction prediction.Briefings in bioinformatics · 2026Article
- A multi-view feature fusion framework with interpretable graph convolution for predicting microbe-drug associations.BMC bioinformatics · 2026Article
- Enhancing Local Functional Structure Features to Improve Drug-Target Interaction Prediction.International journal of molecular sciences · 2025Article
- A survey on deep learning for drug-target binding prediction: models, benchmarks, evaluation, and case studies.Briefings in bioinformatics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Conventional drug discovery is expensive and takes a long period. Drug-target interaction (DTI) prediction through computational methods significantly improves efficiency and reduces costs, holding substantial research value. Despite progress in existing prediction methods, two major challenges remain: first, most methods fail to effectively combine shallow and deep features of protein sequences, overlooking the synergistic effect of both; second, existing feature fusion techniques are relatively simple and struggle to fully capture the complexity and richness of fused features. We suggest an interpretable hybrid deep feature fusion network (IHDFN) as a solution to these problems. In the hybrid deep feature extraction module for protein sequences, shallow and deep features of protein sequences are extracted through two distinct views respectively, which capture multi-level information of proteins comprehensively. To further enhance the feature fusion effect, we introduce the StarNet fusion model in this module, enabling efficient fusion of shallow and deep features and enriching feature representation. To further improve the representation power of drug characteristics and the stability of the model, we use a graph convolutional network (GCN) in the drug feature extraction section in conjunction with residual connections and layer normalization. Furthermore, by integrating multimodal features from drugs and proteins utilizing an attention mechanism in the heterogeneous feature fusion module, we increase the complexity of features and achieve interpretability in predictions by attention focusing. Finally, we experimented on three datasets, and the findings indicate that IHDFN has exceptional performance and robustness compared to other cutting-edge techniques, underscoring its great promise and usefulness in DTI tasks. The code for this study is available on GitHub at https://github.com/wangqhfff/IHDFN.git .
Indexed as
Identifiers
40353937What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.